Drugs / GSK1059615
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00695448 | Jun 2008 → Mar 2009 | cancer | GlaxoSmithKline | Terminated | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK1059615 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00695448 ↗ |
| Known as | GSK-615 | ChEMBL registry synonym — accepted as the source's own label CHEMBL3544966 ↗ |
| Action | Inhibit | “Phosphoinositide 3-Kinase Inhibitor” NCT00695448 ↗ |
| Modality | Small molecule | — CHEMBL3544966 ↗ |
| Route | Oral | “dosed orally once daily” NCT00695448 ↗ |